Table 4.
Most frequently reported adverse events (5% or more) under EGb 761® and pentoxifylline treatment, respectively
| System organ class/event | EGb 761® | Pentoxifylline |
|---|---|---|
| Gastrointestinal disorders | 2 | 11 |
| Diarrhoea | 2 | |
| Abdominal discomfort | 1 | |
| Abdominal distension | 2 | |
| Upper abdominal pain | 4 | |
| Dyspepsia | 1 | |
| Nausea | 2 | |
| Unspecified symptom | 1 | |
| Ear and labyrinth disorders | 6 | 4 |
| Worsening of tinnitus | 5 | 3 |
| Ear discomfort | 1 | |
| Vertigo | 1 | |
| Infections and infestations | 2 | 5 |
| Bronchitis | 1 | 1 |
| Nasopharyngitis | 1 | 2 |
| Gastroenteritis | 1 | |
| Pertussis | 1 |